Jefferies Financial Group’s Boston Scientific BSX Stock Holding History

Jefferies Financial Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,000	Closed	-$4.29M	–	1774
2025 Q4	$4.29M	Buy	+45,000	New	+$4.41M	0.02%	535
2025 Q1	–	Sell	-101,100	Closed	-$9.03M	–	1649
2024 Q4	$9.03M	Sell	101,100 -198,800	-66%	-$17.5M	0.05%	246
2024 Q3	$25.1M	Buy	+299,900	New	+$23.6M	0.18%	72
2023 Q2	–	Sell	-10,000	Closed	-$500K	–	1694
2023 Q1	$500K	Sell	10,000 -52,500	-84%	-$2.47M	﹤0.01%	1090
2022 Q4	$2.89M	Buy	+62,500	New	+$2.71M	0.02%	536

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jefferies Financial Group's BSX Position: Q2 2026 in Review

Jefferies Financial Group reduced its Boston Scientific (BSX) stake by 94% in Q2 2026, selling an estimated $712K and leaving 896 shares worth $38.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

Jefferies Financial Group first reported a position in BSX in Q2 2018 and has held it in 16 quarters since. The position peaked at $66.3M in Q2 2024. 1,485 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Jefferies Financial Group held 896 shares of Boston Scientific worth $38.2K as of Q2 2026.
Jefferies Financial Group sold 13,118 Boston Scientific shares in Q2 2026, an estimated $712K.
Boston Scientific made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1584 holding.
Jefferies Financial Group first reported a position in Boston Scientific in Q2 2018 and has held it in 16 quarters since.
Jefferies Financial Group's Boston Scientific position peaked at $66.3M in Q2 2024.
1,485 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.